Evidence map›Paper›PMID 41612257›Full record

ArticleBMC medical imaging2026

Multimodal deep learning using preoperative CT and ultrasound for recurrence risk prediction in high-grade serous ovarian carcinoma.

Silin Nie, Yumin Jiang, Yanan Duan, Yulu Han, Danni Jiang, Aiping Chen, Huijun Chu

Abstract read
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Silin Nie *Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Yumin Jiang *Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Yanan DuanDepartment of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Yulu HanQingdao Medical College, Qingdao University, Qingdao, Shandong, 266000, China.
Danni JiangUltrasound Section, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Aiping ChenDepartment of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. chenaiping@qdu.edu.cn.
Huijun ChuDepartment of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. chuhuijun@qdu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh-grade serous ovarian carcinoma (HGSOC) is associated with a high risk of postoperative recurrence, and the timing of recurrence is closely related to patient survival outcomes and subsequent treatment strategies. However, current postoperative surveillance primarily relies on clinical indicators and routine imaging examinations, which offer limited predictive accuracy. Although deep learning–based image analysis has shown promise in capturing tumor heterogeneity and improving prognostic assessment, studies integrating preoperative contrast-enhanced computed tomography (CE-CT) and ultrasound imaging for recurrence risk prediction in HGSOC remain limited.

methodsThis single-center retrospective study enrolled 293 patients with pathologically confirmed HGSOC, who were randomly assigned to a training cohort and an internal validation cohort. Separate two-dimensional deep learning survival models were developed using preoperative CE-CT and ultrasound images. A Cox partial likelihood–based time-to-event loss function was applied to generate modality-specific deep learning scores (DL-scores). Independent clinical predictors were identified through univariate and multivariate Cox regression analyses and were integrated with CT-DL and US-DL scores to construct a multimodal Cox prognostic model, which was visualized using a nomogram. Model performance was assessed using the concordance index (C-index), time-dependent receiver operating characteristic (ROC) curves, Kaplan–Meier survival analysis, calibration curves, and decision curve analysis. Bootstrap resampling was performed to evaluate model robustness, and Gradient-weighted Class Activation Mapping (Grad-CAM) was used to visualize model attention.

resultsThe multimodal integrated model demonstrated superior prognostic performance, achieving C-index values of 0.840 in the training cohort and 0.722 in the internal validation cohort. Time-dependent ROC analysis showed that the combined model achieved areas under the curve (AUCs) of 0.880, 0.890, and 0.892 for predicting 1-, 2-, and 3-year recurrence-free survival (RFS) in the training cohort, and 0.864, 0.781, and 0.772 in the validation cohort, respectively. Kaplan–Meier survival analysis revealed a significant separation between high- and low-risk groups (log-rank test, all P < 0.001). Calibration and decision curve analyses indicated good agreement between predicted and observed outcomes and a higher net clinical benefit. Bootstrap resampling further confirmed the robustness of the multimodal model. Grad-CAM visualizations suggested that the model primarily focused on tumor and peritumoral regions.

conclusionsThis study proposes a multimodal prognostic framework integrating deep learning features from CE-CT and ultrasound with clinical variables for preoperative prediction of postoperative recurrence risk in HGSOC. Using routinely acquired imaging data, the model shows consistent interpretability and performance, supporting its use as an exploratory decision-support and risk-stratification tool. Prospective, multicenter validation is required before clinical implementation.

Indexed as

Cystadenocarcinoma, SerousDeep LearningNeoplasm Recurrence, LocalOvarian NeoplasmsTomography, X-Ray ComputedAdultAgedFemaleHumansMiddle AgedMultimodal ImagingNeoplasm GradingPredictive Learning ModelsPrognosisRetrospective StudiesRisk AssessmentCE-CTDeep learningHGSOCMultimodal imagingPrognostic modelRecurrence-free survivalUS

Identifiers

PMID41612257
PMCPMC12924501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.